Game Creek Capital’s Medicines Co MDCO Stock Holding History

Game Creek Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-268,240	Closed	-$7.33M	–	251
2017 Q4	$7.33M	Buy	+268,240	New	+$8.26M	2.04%	12

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Game Creek Capital's MDCO Position: Q1 2018 in Review

Game Creek Capital sold out of Medicines Co (MDCO) in Q1 2018, closing a stake of 268,240 shares — an estimated $7.33M sold.

Game Creek Capital first reported a position in MDCO in Q4 2017 and held it in 1 quarter. The position peaked at $7.33M in Q4 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q1 2018.

Game Creek Capital reported no remaining Medicines Co position as of Q1 2018 after selling out during the quarter.
Game Creek Capital sold 268,240 Medicines Co shares in Q1 2018, an estimated $7.33M.
Game Creek Capital first reported a position in Medicines Co in Q4 2017 and held it in 1 quarter.
Game Creek Capital's Medicines Co position peaked at $7.33M in Q4 2017.
190 funds tracked by Wall St. Rank held Medicines Co as of Q1 2018.

Based on Game Creek Capital's 13F filing for Q1 2018, filed 15 May 2018.